ArticleClinical pharmacology and therapeutics2019

Co-Prescription of Strong CYP1A2 Inhibitors and the Risk of Tizanidine-Associated Hypotension: A Retrospective Cohort Study.

Sandip Chaugai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.